Acasti Pharma Gains Ahead Of Expected Phase II Results By: Benzinga via Benzinga February 26, 2015 at 14:24 PM EST Acasti Pharma Inc (NASDAQ: ACST) gained more than 4 percent Thursday ahead of the expected release of complete data from Phase II ... Read More >>